RBP4 and obesity disorder: In recent years, RBP4 has been proposed to be a cardiometabolic risk factor associated with T2D, obesity and hyperlipidaemia [19] and it appears to induce insulin resistance in skeletal muscle, liver and adipose tissue in vitro [20].